Who are Candidates for Laparoscopic or Open Radical Nephrectomy. Arieh Shalhav

Size: px
Start display at page:

Download "Who are Candidates for Laparoscopic or Open Radical Nephrectomy. Arieh Shalhav"

Transcription

1 Who are Candidates for Laparoscopic or Open Radical Nephrectomy Arieh Shalhav Fritz Duda Chair of Urologic Surgery Professor of Surgery and the Comprehensive Cancer Research Center

2 Who are Candidates for Laparoscopic or Open Radical Nephrectomy Patients who are not candidates for active surveillance Patients with a single kidney or egfr< 60 Patients who are not technically amenable for Nephron Sparing Surgery (Partial Nephrectomy)

3 997 patients older than age 75 diagnosed with renal masses 110 (11%) initially managed with active surveillance Median age 81 y Median tumor size 2.5 cm ( cm) 43% - stable disease 57% - radiographic growth Average growth rate = 0.26 cm /year Not a strong association between tumor size and growth rate REF : Abouasally et al, J Urol 2008

4 Median follow-up 24 months 4 of 110 patients off surveillance Cancer specific survival: 100% No patient developed metastases REF : Abouasally et al, J Urol 2008

5 Small Renal Masses Pathologic Characteristics Based on Tumor Size: Mayo Clinic (n=2,935) Likelihood of RCC strongly associated with tumor size Of tumors < 4 cm, 23% are benign Consider a biopsy! Ref: Frank et al, J Urol 2003

6 Ref: Thompson et al, J Urol 2009

7 Patient Counseling We offer Active Surveillance + - Bx to 1) Elderly and co morbid patients 2) Patients with Chronic renal failure 3) Patients with small renal masses

8 Partial vs. Radical Nephrectomy Radical Nephrectomy is a known risk factor for chronic kidney disease (CKD) 1 CKD associated with CV disease and premature death 2 Nonetheless, radical nephrectomy remains the most common surgical treatment for small renal tumors 3 This may be contributing to increasing mortality in patients with small renal tumors, despite downward stage migration 4 1. Huang WC, Lancet Oncol 7: 735, Hollenbeck BK et al, Urology 67:254, Go AS et al, NEJM 351:1296, Hollingsworth JM et al, JNCI 98:1331, 2006

9

10 Despite normal preoperative serum creatinine levels, 26% of patients with a solitary, small, renal cortical tumour (<4 cm) and two normally functioning kidneys have pre-existing chronic kidney disease Stage 3 (GFR <60 ml/min per 1 73 m 2 ) Surgery related to New onset of estimated GFR < 60; < 45

11

12 1,228 partial nephrectomies from 6 institutions Prior to surgery, 22% had Stage III CKD (GFR: l/min/1.73m 2 ) 29% of pts with preop Stage I, II CKD Stage III or higher CKD Predictors of new Stage III-V CKD: Age, female, tumor size, lower baseline GFR Reference: Clark M et al. J Urol, 2011.

13 Association of Renal Function With Death, Cardiovascular Events, and Hospitalization Reference: Go et al. NEJM, 2004.

14 J Urol 181:55-62, 2009 SEER-Medicare study ( ) Patients 66 yrs Renal tumors 4 cm N = 2,991 2,547 (81%) radical nephrectomy 556 (19%) partial nephrectomy Radical nephrectomy associated with: risk overall mortality (HR 1.38; p < 0.01) 1.4 times greater number of CV events after surgery (p < 0.05)

15 J Urol 179: , 2008 RR 2.16 p = N = 327 pts < 65 yrs pt1a renal tumors 187 PN; 140 RN 10 yr overall survival: 82% RN 93% PN

16 Overuse of Radical Nephrectomy Despite the above data up to 90% of patients with small renal masses undergo radical nephrectomy Technical challenges of LPN vs LRN may be contributing factor We should Partial whenever technically feasible! Especially with GFR< 60 But is partial nephrectomy necessarily better...?

17 541 patients with 5cm renal mass 268 to NSS, 273 to RN Both groups had limited LND T1-2, N0 Normal contralateral kidney

18 10 year overall survival 81.1% RN 75.7% NSS p = progressions, 4 deaths due to RCC for RN 12 progressions, 8 deaths due to RCC for NSS

19 Critique: Incidence of other chronic disease 12.7% NSS vs. 7.7% RN, p=0.055 Crossover: 14.6% in NSS underwent RN vs. 5.9% in RN underwent NSS, p=0.001

20 Open vs. Lap Radical Nephrectomy 61 patients undergoing LRN vs. 33 ORN LRN: Less blood loss (172 vs. 451ml), shorter hospital stay (3.4 vs. 5.2 days), less pain medication (28 vs. 78 mg), quicker return to normal activity (3.6 vs. 8.1 weeks) Same cancer control

21 631 patients LRN, 924 patients ORN from LRN: Longer OR time (219 vs. 182 min), less blood loss (327 vs. 388 ml), lower complication rate (9.8 vs. 15.5%) 5-yr Overall Survival: 93.5% vs. 89.8%, LRN vs. ORN 5-yr RFS: 94.0 vs. 92.8%, LRN vs. ORN No difference when adjusted for age, sex, T stage, tumor grade, BMI

22 23 pts underwent LRN for masses >7cm vs. 25 ORN LRN: Longer operative time (171 vs. 141 min) Less blood loss (227 vs. 536 ml) Shorter hospital stay (6 vs. 11 days) Less postoperative analgesic requirement (45 vs. 112 mg) Better QOL and pain scores to 6 months postop Quicker return to 100% normal health (75 vs. 183 days)?economic impact

23 Open vs. Lap Radical Nephrectomy LRN: Also had shorter incision length (7 vs. 21cm) Up to 50% of patients undergoing ORN have a permanent flank bulge 1 REF : 1 Chatterjee et al, Urol Oncol 2004

24 Technique Lap/ Robotic/ Open Robotic? Increased operative time and cost 1 Transperitoneal vs. Retroperitoneal Equivalent oncologic outcomes at median follow-up 30 months 2 Hand-assisted reported for tumors up to 14cm 3 Technique does not matter think about the patient Bottom line if experience and technical skill exists do minimally invasive. REF : 1 Hemal and Kumar, World J Urol 2009; 2 Ha et al, BJU 2010; 3 Malaeb et al, Urol Oncol 2005

25 The Future... Proceed with Caution Zero Ischemia Partial

26 Thank you. It s good to be in Sao Paolo. Chicago February 2011.

27 Radical Nephrectomy Radical nephrectomy = Gold standard for patients with renal tumors not amenable to partial nephrectomy Outline Who is a candidate for radical nephrectomy? Open vs. Lap Radical Nx: Oncologic efficacies Perioperative complications Laparoscopic approaches transperitoneal, retroperitoneal, robotic Is partial nephrectomy necessarily superior to radical nephrectomy?

Indications For Partial

Indications For Partial Indications For Partial Nephrectomy Christopher G. Wood, M. D., FACS Professor and Deputy Chairman Douglas E. Johnson, M. D. Endowed Professorship in Urology Department of Urology The University of Texas

More information

RAPN. in T1b Renal Masses? A. Mottrie. G. Denaeyer, P. Schatteman, G. Novara

RAPN. in T1b Renal Masses? A. Mottrie. G. Denaeyer, P. Schatteman, G. Novara RAPN in T1b Renal Masses? A. Mottrie G. Denaeyer, P. Schatteman, G. Novara Department of Urology O.L.V. Clinic Aalst OLV Vattikuti Robotic Surgery Institute Aalst Belgium Guidelines on Renal Cell Carcinoma

More information

ELECTIVE PARTIAL NEPHRECTOMY FOR T1B RCC. Vitaly Margulis MD. Associate Professor of Urology

ELECTIVE PARTIAL NEPHRECTOMY FOR T1B RCC. Vitaly Margulis MD. Associate Professor of Urology ELECTIVE PARTIAL NEPHRECTOMY FOR T1B RCC Vitaly Margulis MD Associate Professor of Urology NEPHRON SPARING SURGERY WHY? MAXIMIZING NEPHRON MASS SAVES LIVES ELECTIVE PARTIAL NEPHRECTOMY IF: TECHNICALLY

More information

Vincenzo Ficarra 1,2,3. Associate Editor BJU International

Vincenzo Ficarra 1,2,3. Associate Editor BJU International Partial Nephrectomy for RCC Vincenzo Ficarra 1,2,3 1 Director Department of Urology University of Udine, Italy 2 Associate Editor BJU International 3 Scientific Director OLV Robotic Surgery Institute,

More information

Challenges in RCC surgery. Treatment Goals. Surgical challenges. Management options in VHL associated RCCs

Challenges in RCC surgery. Treatment Goals. Surgical challenges. Management options in VHL associated RCCs Management options in VHL associated RCCs Challenges in RCC surgery JJ PATARD, MD, PhD Paris XI University Observation, Radical nephrectomy, Renal parenchymal sparing surgery, Open, laparoscopic, robotic

More information

Optimal Treatment of ct1b Renal Mass in Patient with Normal GFR: a Role for Radical Nephrectomy?

Optimal Treatment of ct1b Renal Mass in Patient with Normal GFR: a Role for Radical Nephrectomy? Optimal Treatment of ct1b Renal Mass in Patient with Normal GFR: a Role for Radical Nephrectomy? Steven C. Campbell, MD, PhD Program Director, Vice Chairman Department of Urology Center for Urologic Oncology

More information

Research Article Practice Trends in the Surgical Management of Renal Tumors in an Academic Medical Center in the Past Decade

Research Article Practice Trends in the Surgical Management of Renal Tumors in an Academic Medical Center in the Past Decade ISRN Endoscopy Volume 2013, Article ID 945853, 5 pages http://dx.doi.org/10.5402/2013/945853 Research Article Practice Trends in the Surgical Management of Renal Tumors in an Academic Medical Center in

More information

The Surgical Management of RCC

The Surgical Management of RCC The Surgical Management of RCC From Robson to Radiofrequency Ablation Tony Finelli, MD, MSc, FRCSC University Health Network University of Toronto Background Renal cell carcinoma (RCC) is 9 th most common

More information

WHAT IS THE ROLE OF ACTIVE SURVEILLANCE

WHAT IS THE ROLE OF ACTIVE SURVEILLANCE WHAT IS THE ROLE OF ACTIVE SURVEILLANCE IN THE CONTEXT OF RENAL ABLATION AND PARTIAL NEPHRECTOMY? Alessandro Volpe University of Eastern Piedmont Novara, Italy RCC INCIDENCE SEER DATABASE (1975-2006) RCC

More information

Uro-Assiut 2015 Robotic Nephron Sparing Surgery

Uro-Assiut 2015 Robotic Nephron Sparing Surgery Uro-Assiut 2015 Robotic Nephron Sparing Surgery Khaled Fareed, MD, MBA Center for Advanced Laparoscopy, Robotics & Minimally Invasive Surgery Glickman Urological & Kidney Institute Associate Professor,

More information

Laparoscopic Surgery. The Da Vinci Robot. Limits of Laparoscopy. What Robotics Offers. Robotic Urologic Surgery: A New Era in Patient Care

Laparoscopic Surgery. The Da Vinci Robot. Limits of Laparoscopy. What Robotics Offers. Robotic Urologic Surgery: A New Era in Patient Care Laparoscopic Surgery Robotic Urologic Surgery: A New Era in Patient Care Laparoscopic technique was introduced in urologic surgery in the 1990s Benefits: Improved recovery time, decreased morbidity Matthew

More information

Renal Mass Biopsy: Needed Now More than Ever

Renal Mass Biopsy: Needed Now More than Ever Renal Mass Biopsy: Needed Now More than Ever Stuart G. Silverman, MD, FACR Professor of Radiology Harvard Medical School Director, Abdominal Imaging and Intervention Brigham and Women s Hospital Boston,

More information

Rapid communication chronic renal insufficiency after laparoscopic partial nephrectomy and radical nephrectomy for pathologic T1a lesions

Rapid communication chronic renal insufficiency after laparoscopic partial nephrectomy and radical nephrectomy for pathologic T1a lesions Washington University School of Medicine Digital Commons@Becker Open Access Publications 2008 Rapid communication chronic renal insufficiency after laparoscopic partial nephrectomy and radical nephrectomy

More information

Comparison of Glomerular Filtration Rate (GFR) (RCC)

Comparison of Glomerular Filtration Rate (GFR) (RCC) Merit Research Journal of Medicine and Medical Sciences (ISSN: 2354-323X) Vol. 3(10) pp. 467-471, October, 2015 Available online http://www.meritresearchjournals.org/mms/index.htm Copyright 2015 Merit

More information

Presentation of Cases /Audience Voting/Panel/Discussion

Presentation of Cases /Audience Voting/Panel/Discussion Presentation of Cases /Audience Voting/Panel/Discussion JJ Patard Tim O Brien Ninth European International Kidney Cancer Symposium Dublin 25-26 April 2014 Clinical case 1 63 years old women Medical past

More information

Small Renal Mass Guidelines. Clif Vestal, MD USMD Arlington, Texas

Small Renal Mass Guidelines. Clif Vestal, MD USMD Arlington, Texas Small Renal Mass Guidelines Clif Vestal, MD USMD Arlington, Texas Evaluation/Diagnosis 1. Obtain high quality, multiphase, cross-sectional abdominal imaging to optimally characterize/stage the renal mass.

More information

What is the role of partial nephrectomy in the context of active surveillance and renal ablation?

What is the role of partial nephrectomy in the context of active surveillance and renal ablation? What is the role of partial nephrectomy in the context of active surveillance and renal ablation? Dogu Teber Department of Urology University Hospital Heidelberg Coming from Heidelberg obligates to speak

More information

ablativi Vincenzo Ficarra Direttore Clinica di Urologia Azienda Ospedaliera Universitaria di Udine

ablativi Vincenzo Ficarra Direttore Clinica di Urologia Azienda Ospedaliera Universitaria di Udine Sorveglianza attiva e trattamenti ablativi Vincenzo Ficarra Direttore Clinica di Urologia Azienda Ospedaliera Universitaria di Udine Risk of mortality in RCC patients Kutikov A. et al. J Clin Oncol 2010;

More information

Surgical Management of Renal Cancer. David Nicol Consultant Urologist

Surgical Management of Renal Cancer. David Nicol Consultant Urologist Surgical Management of Renal Cancer David Nicol Consultant Urologist Roles of Surgery 1. Curative intervention localised disease 2. Symptomatic control advanced disease 3. Augmentation of efficacy of systemic

More information

Key Words: kidney; carcinoma, renal cell; renal insufficiency; nephrectomy; mortality

Key Words: kidney; carcinoma, renal cell; renal insufficiency; nephrectomy; mortality Comparative Effectiveness for Survival and Renal Function of Partial and Radical Nephrectomy for Localized Renal Tumors: A Systematic Review and Meta-Analysis Simon P. Kim, R. Houston Thompson, Stephen

More information

AUA Guidelines Renal Mass and Localized Kidney Cancer

AUA Guidelines Renal Mass and Localized Kidney Cancer AUA Guidelines Renal Mass and Localized Kidney Cancer Steven C. Campbell, MD, PhD Chair AUA Guidelines Panel Professor Surgery, Vice Chair, Program Director Department of Urology Glickman Urological and

More information

Surgical Management of VHL-related Renal Cancers. Disclosures. Glossary. Overview. none

Surgical Management of VHL-related Renal Cancers. Disclosures. Glossary. Overview. none Surgical Management of VHL-related Renal Cancers Disclosures Presentation to the VHL Family Alliance Annual Meeting, Denver, CO October 20, 2018 none Adam R. Metwalli, M.D. Professor & Chief, Division

More information

Patient Selection for Surgery in RCC with Thrombus. E. Jason Abel, M.D.

Patient Selection for Surgery in RCC with Thrombus. E. Jason Abel, M.D. Patient Selection for Surgery in RCC with Thrombus E. Jason Abel, M.D. RCC with venous invasion Venous invasion occurs in ~10% of RCC Surgery more complex Increased risk for morbidity Thrombus may be confined

More information

S.C.D.U. Urologia Dir.: prof. Francesco Porpiglia

S.C.D.U. Urologia Dir.: prof. Francesco Porpiglia UNIVERSITA degli STUDI di TORINO Facolta di Medicina e Chirurgia, Polo San Luigi Dipartimento di Oncologia S.C.D.U. Urologia Dir.: prof. Francesco Porpiglia A.O.U. San Luigi Gonzaga Orbassano Chirurgia:

More information

St. Dominic s Annual Cancer Report Outcomes

St. Dominic s Annual Cancer Report Outcomes St. Dominic s 2017 Annual Cancer Report Outcomes Cancer Program Practice Profile Reports (CP3R) St. Dominic s Cancer Committee monitors and ensures that patients treated at St. Dominic Hospital receive

More information

Canadian Guidelines for Management of the Small Renal Mass (SRM)

Canadian Guidelines for Management of the Small Renal Mass (SRM) Canadian Guidelines for Management of the Small Renal Mass (SRM) Michael A.S. Jewett*, Ricardo Rendon, Louis Lacombe, Pierre I. Karakiewicz, Simon Tanguay, Wes Kassouf, Mike Leveridge, Ilias Cagiannos,

More information

Is renal cryoablation becoming an effective alternative to partial nephrectomy?

Is renal cryoablation becoming an effective alternative to partial nephrectomy? Is renal cryoablation becoming an effective alternative to partial nephrectomy? J GARNON 1, G TSOUMAKIDOU 1, H LANG 2, A GANGI 1 1 department of interventional radiology 2 department of urology University

More information

Laparoscopic Radical Nephrectomy- the current gold standard

Laparoscopic Radical Nephrectomy- the current gold standard Laparoscopic Radical Nephrectomy- the current gold standard Anoop M. Meraney, M.D Director, Urologic Oncology, Helen and Harry Gray Cancer Center, Hartford Hospital and Connecticut Surgical Group. Is it

More information

Partial Nephrectomy Planning: Everybody s s doing it, you can to

Partial Nephrectomy Planning: Everybody s s doing it, you can to Partial Nephrectomy Planning: Everybody s s doing it, you can to Brian R. Herts, MD Associate Professor of Radiology Head, Abdominal Imaging, Imaging Institute & Staff, The Glickman Urological and Kidney

More information

Lymphadenectomy in RCC: Yes, No, Clinical Trial?

Lymphadenectomy in RCC: Yes, No, Clinical Trial? Lymphadenectomy in RCC: Yes, No, Clinical Trial? Viraj Master MD PhD FACS Professor Associate Chair for Clinical Affairs and Quality Director of Clinical Research Unit Department of Urology Emory University

More information

Comparison of Partial and Radical Nephrectomy for pt1b Renal Cell Carcinoma

Comparison of Partial and Radical Nephrectomy for pt1b Renal Cell Carcinoma www.kjurology.org DOI:10.4111/kju.2010.51.9.596 Urological Oncology Comparison of Partial and Radical Nephrectomy for pt1b Renal Cell Carcinoma Jong Min Kim, Phil Hyun Song, Hyun Tae Kim, Tong Choon Park

More information

Overall Survival and Development of Stage IV Chronic Kidney Disease in Patients Undergoing Partial and Radical Nephrectomy for Benign Renal Tumors

Overall Survival and Development of Stage IV Chronic Kidney Disease in Patients Undergoing Partial and Radical Nephrectomy for Benign Renal Tumors EUROPEAN UROLOGY 64 (2013) 600 606 available at www.sciencedirect.com journal homepage: www.europeanurology.com Platinum Priority Kidney Cancer Editorial by Alexander Kutikov, Marc C. Smaldone and Robert

More information

Partial Nephrectomy Is Associated with Improved Overall Survival Compared to Radical Nephrectomy in Patients with Unanticipated Benign Renal Tumours

Partial Nephrectomy Is Associated with Improved Overall Survival Compared to Radical Nephrectomy in Patients with Unanticipated Benign Renal Tumours EUROPEAN UROLOGY 58 (2010) 293 298 available at www.sciencedirect.com journal homepage: www.europeanurology.com Kidney Cancer Partial Nephrectomy Is Associated with Improved Overall Survival Compared to

More information

Surgery of Renal Cell Carcinoma Axel Bex, MD, PhD The Netherlands Cancer Institute

Surgery of Renal Cell Carcinoma Axel Bex, MD, PhD The Netherlands Cancer Institute Surgery of Renal Cell Carcinoma Axel Bex, MD, PhD The Netherlands Cancer Institute 23 March 2012, Sao Paulo, Brazil Surgery of RCC Locally confined (small) renal tumours Locally advanced disease Metastatic

More information

Guidelines for the Management of Renal Cancer West Midlands Expert Advisory Group for Urological Cancer

Guidelines for the Management of Renal Cancer West Midlands Expert Advisory Group for Urological Cancer Guidelines for the Management of Renal Cancer West Midlands Expert Advisory Group for Urological Cancer West Midlands Clinical Networks and Clinical Senate Coversheet for Network Expert Advisory Group

More information

Arieh L. Shalhav Is There a Risk in Robotic Nephroureterectomy?

Arieh L. Shalhav Is There a Risk in Robotic Nephroureterectomy? Arieh L. Shalhav Is There a Risk in Robotic Nephroureterectomy? 80 patients LNU (n = 40) or ONU (n = 40) CSS (p = 0.2), BRFS (p = 0.86), MFS (p = 0.12) similar for the entire cohort Subgroups of pt3 UTUC

More information

LAPAROSCOPIC RADICAL NEPHRECTOMY FOR LARGE (GREATER THAN 7 CM, T2) RENAL TUMORS

LAPAROSCOPIC RADICAL NEPHRECTOMY FOR LARGE (GREATER THAN 7 CM, T2) RENAL TUMORS 0022-5347/04/1726-2172/0 Vol. 172, 2172 2176, December 2004 THE JOURNAL OF UROLOGY Printed in U.S.A. Copyright 2004 by AMERICAN UROLOGICAL ASSOCIATION DOI: 10.1097/01.ju.0000140961.53335.04 LAPAROSCOPIC

More information

Complications in robotic surgery!! Review of the literature! RALP, RAPN and RARC!

Complications in robotic surgery!! Review of the literature! RALP, RAPN and RARC! Complications in robotic surgery Review of the literature RALP, RAPN and RARC Anna Wallerstedt, MD Karolinska University Hospital Stockholm, Sweden Agenda The importance of reporting surgical complications

More information

Tumor necrosis is a strong predictor for recurrence in patients with pathological T1a renal cell carcinoma

Tumor necrosis is a strong predictor for recurrence in patients with pathological T1a renal cell carcinoma ONCOLOGY LETTERS 9: 125-130, 2015 Tumor necrosis is a strong predictor for recurrence in patients with pathological T1a renal cell carcinoma KEIICHI ITO 1, KENJI SEGUCHI 1, HIDEYUKI SHIMAZAKI 2, EIJI TAKAHASHI

More information

Surgical Management of Metastatic and Locally Recurrent Kidney Cancer: Does it Make Sense?

Surgical Management of Metastatic and Locally Recurrent Kidney Cancer: Does it Make Sense? Surgical Management of Metastatic and Locally Recurrent Kidney Cancer: Does it Make Sense? Philippe E. Spiess, MD, FACS Associate Member Department of GU Oncology Department of Tumor Biology Moffitt Cancer

More information

TITLE: Management of Small Renal Masses: American Society of Clinical Oncology Clinical Practice Guideline

TITLE: Management of Small Renal Masses: American Society of Clinical Oncology Clinical Practice Guideline TITLE: Management of Small Renal Masses: American Society of Clinical Oncology Clinical Practice Guideline Table of Contents Data Supplement 1: Additional Evidence Table(s) Characteristics of Studies Identified

More information

Original Article - Urological Oncology

Original Article - Urological Oncology www.kjurology.org http://dx.doi.org/10.4111/kju.2014.55.7.446 Original Article - Urological Oncology http://crossmark.crossref.org/dialog/?doi=10.4111/kju.2014.55.7.446&domain=pdf&date_stamp=2014-07-16

More information

Systematic review of oncological outcomes following surgical management of localised renal cancer

Systematic review of oncological outcomes following surgical management of localised renal cancer MacLennan S, Imamura M, Lapitan MC, Omar MI, Lam TB, Hilvano-Cabungcal AM et al. Systematic review of oncological outcomes following surgical management of localised renal cancer. European Urology 2012;61:972-93.

More information

NCCN AND AUA GUIDELINES FOR RCC:

NCCN AND AUA GUIDELINES FOR RCC: NCCN AND AUA GUIDELINES FOR RCC: DO THEY EFFECTIVELY CAPTURE RECURRENCES FOLLOWING NEPHRECTOMY? Suzanne B. Stewart, MD 1, R. Houston Thompson, MD 1, Sarah P. Psutka, MD 1, John C. Cheville, MD 2, Christine

More information

Partial Nephrectomy: Does Ischemia Matter?

Partial Nephrectomy: Does Ischemia Matter? Partial Nephrectomy: Does Ischemia Matter? Karim Touijer, MD, MPH Attending Surgeon Memorial Sloan-Kettering Cancer Center Associate Professor of Urology Weill Cornell Medical College, New York No disclosures

More information

Renal Mass Biopsy Should be Used for Most SRM - PRO

Renal Mass Biopsy Should be Used for Most SRM - PRO Renal Mass Biopsy Should be Used for Most SRM - PRO Tony Finelli, MD, MSc, FRCSC Head, Division of Urology GU Site Lead, Princess Margaret Cancer Center GU Cancer Lead, Cancer Care Ontario Associate Professor,

More information

Renal biopsy is mandatory for every small renal mass

Renal biopsy is mandatory for every small renal mass Renal biopsy is mandatory for every small renal mass Ben Challacombe Consultant Urologist The Urology Centre Guy s and St. Thomas Hospital NHS Foundation Trust Oncocytoma High Risk Partial converted to

More information

Florida Cancer Specialist & Research Institute, Sebastian and Vero Beach, Fl, USA 3

Florida Cancer Specialist & Research Institute, Sebastian and Vero Beach, Fl, USA 3 Evaluation of Perioperative Outcomes and Renal Function after Robotic Assisted Laparoscopic Partial Nephrectomy Off/On Clamp: Comparison of ct1a versus ct1b Renal Masses Hugo H Davila 1-4*, Raul E Storey

More information

Treatment of Invasive Bladder Cancer in the Elderly and Frail Pa9ent

Treatment of Invasive Bladder Cancer in the Elderly and Frail Pa9ent Treatment of Invasive Bladder Cancer in the Elderly and Frail Pa9ent Jehonathan H Pinthus MD, Ph.D, FRCSC Associate Professor Department of Surgery/Urology McMaster University Life expectancy Current age

More information

Introduction. Original Article: Clinical Investigation

Introduction. Original Article: Clinical Investigation International Journal of Urology (2019) 26, 120--125 doi: 10.1111/iju.13819 Original Article: Clinical Investigation Hypertension and diabetes mellitus are not associated with worse renal functional outcome

More information

RCC in Adolescents and Young Adults (AYAs): Diagnosis and Management

RCC in Adolescents and Young Adults (AYAs): Diagnosis and Management RCC in Adolescents and Young Adults (AYAs): Diagnosis and Management Nicholas G. Cost, M.D. Assistant Professor, Department of Surgery, Division of Urology University of Colorado Cancer Center Fifteenth

More information

Role of computed tomography-calculated intraparenchymal tumor volume in assessment of patients undergoing partial nephrectomy

Role of computed tomography-calculated intraparenchymal tumor volume in assessment of patients undergoing partial nephrectomy International Journal of Urology (2018) 25, 436--441 doi: 10.1111/iju.13531 Original Article: Clinical Investigation Role of computed tomography-calculated intraparenchymal tumor volume in assessment of

More information

Supplementary Table 2. Surgical prophylaxis: Summary of selected series which included prophylactic management against the risk of bleeding.

Supplementary Table 2. Surgical prophylaxis: Summary of selected series which included prophylactic management against the risk of bleeding. Supplementary Tables of the article The Risks of Renal Angiomyolipoma: Reviewing the Evidence. Supplementary Table 2. Surgical prophylaxis: Summary of selected series which included prophylactic management

More information

Directness Consistency Precision Reporting Bias

Directness Consistency Precision Reporting Bias responsible for the accuracy and presentation of the material. Supplemental Table. Strength of evidence for primary. Key Outcomes* Studies (N) Study limitations Directness Consistency Precision Reporting

More information

Early radical cystectomy in NMIBC Marko Babjuk

Early radical cystectomy in NMIBC Marko Babjuk Early radical cystectomy in NMIBC Marko Babjuk Dept. of Urology, 2nd Faculty of Medicine, Hospital Motol, Praha, Czech Republic We Are The European Association of Urology We Are Urologists, residents,

More information

Partial Nephrectomy Techniques for Renal Preservation: Historical and Modern Approaches

Partial Nephrectomy Techniques for Renal Preservation: Historical and Modern Approaches Partial Nephrectomy Techniques for Renal Preservation: Historical and Modern Approaches Cary N Robertson MD FACS Associate Professor Division of Urology Associate Director Urologic Oncology Duke Cancer

More information

Recent Developments in Research on Kidney Cancer: Highlights from Urological and Oncological Congresses in 2007

Recent Developments in Research on Kidney Cancer: Highlights from Urological and Oncological Congresses in 2007 european urology supplements 7 (2008) 494 507 available at www.sciencedirect.com journal homepage: www.europeanurology.com Recent Developments in Research on Kidney Cancer: Highlights from Urological and

More information

GUIDELINES ON RENAL CELL CARCINOMA

GUIDELINES ON RENAL CELL CARCINOMA GUIDELINES ON RENAL CELL CARCINOMA B. Ljungberg (chairman), D.C. Hanbury, M.A. Kuczyk, A.S. Merseburger, P.F.A. Mulders, J-J. Patard, I.C. Sinescu Introduction This EAU guideline was prepared to help urologists

More information

Killing Tumors with Scans Not Scalpels: Kidney Cancer Ablation. Basics. What is Percutaneous Ablation? Where are your kidneys?

Killing Tumors with Scans Not Scalpels: Kidney Cancer Ablation. Basics. What is Percutaneous Ablation? Where are your kidneys? Killing Tumors with Scans Not Scalpels: Kidney Cancer Ablation Ronald J. Zagoria, M.D. UCSF Professor and Vice Chair Abdominal Imaging Section Chief Basics Where are your kidneys? What is ablation? Facts

More information

Ureteroscopy Is Indicated in every patient with suspected Upper Tract Urothelial Tumor

Ureteroscopy Is Indicated in every patient with suspected Upper Tract Urothelial Tumor Ureteroscopy Is Indicated in every patient with suspected Upper Tract Urothelial Tumor Scott G. Hubosky, MD The Demetrius H. Bagley Jr., MD Associate Professor of Urology Director of Endourology Vice Chair

More information

Preservation of Renal Function Following Partial or Radical Nephrectomy Using 24-Hour Creatinine Clearance

Preservation of Renal Function Following Partial or Radical Nephrectomy Using 24-Hour Creatinine Clearance european urology 54 (2008) 143 152 available at www.sciencedirect.com journal homepage: www.europeanurology.com Kidney Cancer Preservation of Renal Function Following Partial or Radical Nephrectomy Using

More information

Nephron-sparing surgery (NSS) has become the standard

Nephron-sparing surgery (NSS) has become the standard JOURNAL OF ENDOUROLOGY Volume 27, Number 7, July 2013 ª Mary Ann Liebert, Inc. Pp. 869 874 DOI: 10.1089/end.2013.0023 Robot-Assisted Partial Nephrectomy: A Comparison of the Transperitoneal and Retroperitoneal

More information

Methods. Surgery. Patient population. Volumetric analysis. Statistical analysis. Ethical approval

Methods. Surgery. Patient population. Volumetric analysis. Statistical analysis. Ethical approval International Journal of Urology (2018) 25, 359--364 doi: 10.1111/iju.13529 Original Article: Clinical Investigation Robot-assisted laparoscopic partial nephrectomy versus laparoscopic partial nephrectomy:

More information

BJUI. Robotic nephrectomy for the treatment of benign and malignant disease

BJUI. Robotic nephrectomy for the treatment of benign and malignant disease . JOURNAL COMPILATION 2008 BJU INTERNATIONAL Laparoscopic and Robotic Urology ROGERS et al. BJUI BJU INTERNATIONAL Robotic nephrectomy for the treatment of benign and malignant disease Craig Rogers, Rajesh

More information

Presentation with lymphadenopathy

Presentation with lymphadenopathy Presentation with lymphadenopathy Theo M. de Reijke MD PhD FEBU Department of Urology Academic Medical Center Amsterdam Rationale for RRP in N+ disease Prevention local problems Better survival in limited

More information

Management of Locally Reccurent Renal Cell Carcinoma. Jose A. Karam, MD, FACS Assistant Professor Department of Urology

Management of Locally Reccurent Renal Cell Carcinoma. Jose A. Karam, MD, FACS Assistant Professor Department of Urology Management of Locally Reccurent Renal Cell Carcinoma Jose A. Karam, MD, FACS Assistant Professor Department of Urology DefiniAons Defini&ve treatment Aiming for cure Abla&on therapy Radiofrequency abla&on

More information

Clinical Study A Single Surgeon s Experience with Open, Laparoscopic, and Robotic Partial Nephrectomy

Clinical Study A Single Surgeon s Experience with Open, Laparoscopic, and Robotic Partial Nephrectomy International Scholarly Research Notices, Article ID 430914, 5 pages http://dx.doi.org/10.1155/2014/430914 Clinical Study A Single Surgeon s Experience with Open, Laparoscopic, and Robotic Partial Nephrectomy

More information

Contemporary Role of Renal Mass Biopsy

Contemporary Role of Renal Mass Biopsy Contemporary Role of Renal Mass Biopsy Jeffrey K. Mullins, MD Director Urologic Oncology CHI Memorial Chattanooga Urology Associates September 8, 2018 Disclosures I, Jeffrey Mullins, do not have a financial

More information

Should the primary be treated in patients with metastatic disease? Upper Tract Urothelial Cancer

Should the primary be treated in patients with metastatic disease? Upper Tract Urothelial Cancer Should the primary be treated in patients with metastatic disease? Upper Tract Urothelial Cancer Seth P. Lerner, MD, FACS Professor, Scott Department of Urology Beth and Dave Swalm Chair in Urologic Oncology

More information

Partial versus radical nephrectomy for pt1a renal cancer in Serbia

Partial versus radical nephrectomy for pt1a renal cancer in Serbia JBUON 2016; 21(6): 1449-1453 ISSN: 1107-0625, online ISSN: 2241-6293 www.jbuon.com E-mail: editorial_office@jbuon.com ORIGINAL ARTICLE Partial versus radical nephrectomy for pt1a renal cancer in Serbia

More information

Surgeons Perspective: LN as a Draining Pattern. Jose A. Karam, MD, FACS Associate Professor Department of Urology

Surgeons Perspective: LN as a Draining Pattern. Jose A. Karam, MD, FACS Associate Professor Department of Urology Surgeons Perspective: LN as a Draining Pattern Jose A. Karam, MD, FACS Associate Professor Department of Urology Disclosures EMD Serono, Pfizer, Novartis: Advisory board/consultant Disclosures I perform

More information

Laparoscopic Radical Nephrectomy for Renal Masses 7 Centimeters or Larger

Laparoscopic Radical Nephrectomy for Renal Masses 7 Centimeters or Larger SCIENTIFIC PAPER Laparoscopic Radical Nephrectomy for Renal Masses 7 Centimeters or Larger James S. Rosoff, MD, Jay D. Raman, MD, R. Ernest Sosa, MD, Joseph J. Del Pizzo, MD ABSTRACT Objective: To report

More information

Vincenzo Ficarra. Direttore Clinica di Urologia Azienda Ospedaliera Universitaria di Udine

Vincenzo Ficarra. Direttore Clinica di Urologia Azienda Ospedaliera Universitaria di Udine Best Papers on Kidney Cancer Vincenzo Ficarra Direttore Clinica di Urologia Azienda Ospedaliera Universitaria di Udine Uro-oncological oncological topics Renal Tumor biopsy Positive Surgical Margins after

More information

ROBOTIC VS OPEN RADICAL CYSTECTOMY

ROBOTIC VS OPEN RADICAL CYSTECTOMY ROBOTIC VS OPEN RADICAL CYSTECTOMY A REVIEW Colin Lundeen December 14, 2016 Objectives Review the history of radical cystectomy Critically analyze recent RCTs comparing open radical cystectomy (ORC) to

More information

ROBOTIC SURGERY FOR RENAL CELL CANCER CLAYTON LAU, MD CHIEF OF UROLOGY AND UROLOGIC ONCOLOGY SEPT 2018

ROBOTIC SURGERY FOR RENAL CELL CANCER CLAYTON LAU, MD CHIEF OF UROLOGY AND UROLOGIC ONCOLOGY SEPT 2018 ROBOTIC SURGERY FOR RENAL CELL CANCER CLAYTON LAU, MD CHIEF OF UROLOGY AND UROLOGIC ONCOLOGY SEPT 2018 Disclosures Consultant and Speaker for Intuitive Surgical and Covidien 2. Epidemiology 62K Estimated

More information

Guidelines on Renal Cell

Guidelines on Renal Cell Guidelines on Renal Cell Carcinoma (Text update March 2009) B. Ljungberg (Chairman), D.C. Hanbury, M.A. Kuczyk, A.S. Merseburger, P.F.A. Mulders, J-J. Patard, I.C. Sinescu Introduction Renal cell carcinoma

More information

Donation from Old Living Donors How safe is it? Safe for recipient or donor?

Donation from Old Living Donors How safe is it? Safe for recipient or donor? Donation from Old Living Donors How safe is it? Safe for recipient or donor? Pr Lionel Rostaing Service de Néphrologie, Hémodialyse, Aphérèses et Transplantation CHU Grenoble Alpes France lrostaing@chu-grenoble.fr

More information

Prostate Cancer Incidence

Prostate Cancer Incidence Prostate Cancer: Prevention, Screening and Treatment Philip Kantoff MD Dana-Farber Cancer Institute Professor of fmedicine i Harvard Medical School Prostate Cancer Incidence # of patients 350,000 New Cases

More information

Single-center comparison of purely laparoscopic, hand-assisted laparoscopic, and open radical nephrectomy in patients at high anesthetic risk

Single-center comparison of purely laparoscopic, hand-assisted laparoscopic, and open radical nephrectomy in patients at high anesthetic risk Single-center comparison of purely laparoscopic, hand-assisted laparoscopic, and open radical nephrectomy in patients at high anesthetic risk Baldwin D D, Dunbar J A, Parekh D J, Wells N, Shuford M D,

More information

Canadian Urological Association guidelines for followup of patients after treatment of nonmetastatic

Canadian Urological Association guidelines for followup of patients after treatment of nonmetastatic Canadian Urological Association guidelines for followup of patients after treatment of nonmetastatic renal cell carcinoma Wassim Kassouf, Leonardo L. Monteiro, Darrel E. Drachenberg, Adrian S. Fairey,

More information

Debate: Lymphadenectomy is Important in mrcc, CON P. Mulder, M.D., Ph.D. JJ. Patard, MD, Ph.D.

Debate: Lymphadenectomy is Important in mrcc, CON P. Mulder, M.D., Ph.D. JJ. Patard, MD, Ph.D. Debate: Lymphadenectomy is Important in mrcc, CON P. Mulder, M.D., Ph.D. JJ. Patard, MD, Ph.D.. Eighth European International Kidney Cancer Symposium Budapest 03-04 May 2013 The role of LND In organ confined

More information

GUIDELINES ON RENAL CELL CANCER

GUIDELINES ON RENAL CELL CANCER 20 G. Mickisch (chairman), J. Carballido, S. Hellsten, H. Schulze, H. Mensink Eur Urol 2001;40(3):252-255 Introduction is characterised by a constant rise in incidence over the last 50 years, with a predominance

More information

Trend of Surgical Treatment of Localized Renal Cell Carcinoma

Trend of Surgical Treatment of Localized Renal Cell Carcinoma Ramzi B Jabaji, MD 1 ; Heidi Fischer, PhD 2 ; Tyler Kern, MD 1 ; Gary W Chien, MD 1 Perm J 2019;23:18-108 E-pub: 01/07/2019 https://doi.org/10.7812/tpp/18-108 ABSTRACT Introduction: Rapid adoption of robotics

More information

Association between R.E.N.A.L. nephrometry score and perioperative outcomes following open partial nephrectomy under cold ischemia

Association between R.E.N.A.L. nephrometry score and perioperative outcomes following open partial nephrectomy under cold ischemia original research Association between R.E.N.A.L. nephrometry score and perioperative outcomes following open partial nephrectomy under cold ischemia Dong Soo Park, MD; * Jin Ho Hwang, MD; * Moon Hyung

More information

Comparison of Long-Term Results After Nephron-Sparing Surgery and Radical Nephrectomy in Treating 4- to 7-cm Renal Cell Carcinoma

Comparison of Long-Term Results After Nephron-Sparing Surgery and Radical Nephrectomy in Treating 4- to 7-cm Renal Cell Carcinoma :3-8 3 Comparison of Long-Term Results After Nephron-Sparing Surgery and Radical Nephrectomy in Treating 4- to 7-cm Renal Cell Carcinoma Daimantas Milonas, Giedrius Skulčius, Ruslanas Baltrimavičius, Stasys

More information

Presentation with lymphadenopathy

Presentation with lymphadenopathy Presentation with lymphadenopathy Theo M. de Reijke MD PhD FEBU Department of Urology Academic Medical Center Amsterdam Rationale for RRP in N+ disease Prevention local problems Better survival in limited

More information

When to Integrate Surgery for Metatstatic Urothelial Cancers

When to Integrate Surgery for Metatstatic Urothelial Cancers When to Integrate Surgery for Metatstatic Urothelial Cancers Wade J. Sexton, M.D. Senior Member and Professor Department of Genitourinary Oncology Moffitt Cancer Center Case Presentation #1 67 yo male

More information

Upper Tract Urothelial Cancers Nephron Sparing Strategies

Upper Tract Urothelial Cancers Nephron Sparing Strategies Upper Tract Urothelial Cancers Nephron Sparing Strategies Girish Kulkarni, MD, PhD, FRCSC Urologic surgeon, Division of Urology Princess Margaret Hospital, University Health Network Assistant Professor,

More information

Can we predict which patients will evolve to chronic kidney disease after nephrectomy for cortical renal tumors?

Can we predict which patients will evolve to chronic kidney disease after nephrectomy for cortical renal tumors? ORIGINAL Article Vol. 38 (5): 637-644, September - October, 2012 Can we predict which patients will evolve to chronic kidney disease after nephrectomy for cortical renal tumors? Fabio Cesar Miranda Torricelli,

More information

BJUI. Active surveillance of small renal masses offers short-term oncological efficacy equivalent to radical and partial nephrectomy

BJUI. Active surveillance of small renal masses offers short-term oncological efficacy equivalent to radical and partial nephrectomy BJUI Active surveillance of small renal masses offers short-term oncological efficacy equivalent to radical and partial nephrectomy Nilay Patel, David Cranston, M. Zeeshan Akhtar, Caroline George, Andrew

More information

SAMPLING OF POST NEPHRECTOMY CANCER CARE (5)

SAMPLING OF POST NEPHRECTOMY CANCER CARE (5) SAMPLING OF POST NEPHRECTOMY CANCER CARE (5) Universally recognized post-nephrectomy cancer treatment. Sampling: National Comprehensive Cancer Network (NCCN) NCCN Clinical Practice Guidelines in Oncology

More information

Timing of targeted therapy in patients with low volume mrcc. Eli Rosenbaum Davidoff Cancer Center Beilinson Hospital

Timing of targeted therapy in patients with low volume mrcc. Eli Rosenbaum Davidoff Cancer Center Beilinson Hospital 1 Timing of targeted therapy in patients with low volume mrcc Eli Rosenbaum Davidoff Cancer Center Beilinson Hospital 2 Wont be discussing: Symptomatic patients High volume disease Rapidly growing metastases

More information

Comparison of radiographic and pathologic sizes of renal tumors

Comparison of radiographic and pathologic sizes of renal tumors ORIGINAL Article Vol. 39 (2): 189-194, March - April, 2013 doi: 10.1590/S1677-5538.IBJU.2013.02.06 Comparison of radiographic and pathologic sizes of renal tumors Wei Chen, Linhui Wang, Qing Yang, Bing

More information

Urothelial Tumors of the Upper Tract: Diagnosis and Management. Daniel Rapoport April 11, 2007 Urology Grand Rounds

Urothelial Tumors of the Upper Tract: Diagnosis and Management. Daniel Rapoport April 11, 2007 Urology Grand Rounds Urothelial Tumors of the Upper Tract: Diagnosis and Management Daniel Rapoport April 11, 2007 Urology Grand Rounds 1 Overview Background Epidemiology and risk factors Natural history and prognostic factors

More information

Shape the Future of Urological Surgery

Shape the Future of Urological Surgery Shape the Future of Urological Surgery THE ROLE OF LAPAROSCOPIC SURGERY IN NEW MILENNIUM Victor Chia-Hsiang Lin, MD Division of Urology, Department of Surgery Chi-Mei Medical Center MY TALK TODAY IS Minimal

More information

Prediction of complications after partial nephrectomy by RENAL nephrometry score

Prediction of complications after partial nephrectomy by RENAL nephrometry score UROLOGY Ann R Coll Surg Engl 04; 96: 475 479 doi 0.308/00358844X3946849035 Prediction of complications after partial nephrectomy by RENAL nephrometry score UD Reddy, R Pillai, RA Parker, J Weston, NA Burgess,

More information

Tratamiento adyuvante y neoadyuvante del cáncer renal en Xavier Garcia del Muro Solans Institut Català d Oncologia Hospitalet.

Tratamiento adyuvante y neoadyuvante del cáncer renal en Xavier Garcia del Muro Solans Institut Català d Oncologia Hospitalet. Tratamiento adyuvante y neoadyuvante del cáncer renal en 2017 Xavier Garcia del Muro Solans Institut Català d Oncologia Hospitalet. Barcelona Pronóstico del CR mediante un sistema integrado en 468 pts

More information

Retroperitoneoscopic Radical Nephrectomy: Initial Experience

Retroperitoneoscopic Radical Nephrectomy: Initial Experience Retroperitoneoscopic Radical Nephrectomy: Initial Experience A. Hasegan 1, D. Bratu 2, V. Pirvut 1, I. Mihai 1, N. Grigore 1 1 Lucian Blaga University of Sibiu, Department of Urology 2 Lucian Blaga University

More information

Multidisciplinary approach for renal cell carcinoma Axel Bex, MD, PhD The Netherlands Cancer Institute

Multidisciplinary approach for renal cell carcinoma Axel Bex, MD, PhD The Netherlands Cancer Institute Multidisciplinary approach for renal cell carcinoma Axel Bex, MD, PhD The Netherlands Cancer Institute 20 April, Antalya, Turkey RCC European Union 60.000 new diagnoses/year 26.000 Cancer related deaths

More information

Università di Roma La Sapienza

Università di Roma La Sapienza Università di Roma La Sapienza U.O.C. Chirurgia Pediatrica - Policlinico Umberto I Direttore: Prof Francesco Cozzi Chirurgia nephron-sparing per tumori renali primitivi in età pediatrica. Prof. Denis A.

More information